VITREAL LEVELS OF ERYTHROPOIETIN ARE INCREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION AND CORRELATE WITH VITREAL VEGF AND THE EXTENT OF MACULAR EDEMA

COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

(2009) LIHTEH WU et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy

(2009) Maria Stephanie R. Jardeleza et al.   Seminars in Ophthalmology

Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia

(2008) Michael A. van der Kooij et al.   BRAIN RESEARCH REVIEWS

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

(2008) K Kriechbaum et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Expression of Erythropoietin and Its Receptor in the Human Retina: A comparative study of diabetic and nondiabetic subjects

(2008) M. Garcia-Ramirez et al.   DIABETES CARE

Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study

(2008) Marilita M. Moschos et al.   DOCUMENTA OPHTHALMOLOGICA

Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema

(2008) J Garcí-Arumí et al.   EYE

Differential Neuroprotective Properties of Endogenous and Exogenous Erythropoietin in a Mouse Model of Traumatic Brain Injury

(2008) Na'ama A. Shein et al.   JOURNAL OF NEUROTRAUMA

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator

(2008) Peter A Campochiaro et al.   MOLECULAR THERAPY